Skip to main content

Aclaris Therapeutics, Inc. (ACRS)

NASDAQ: ACRS · IEX Real-Time Price · USD
1.05
-0.02 (-1.87%)
At close: Dec 29, 2023, 4:00 PM
1.08
+0.03 (2.86%)
After-hours: Dec 29, 2023, 7:57 PM EST

Aclaris Therapeutics Revenue

Aclaris Therapeutics had revenue of $21.43M in the twelve months ending September 30, 2023, down -8.80% year-over-year. Revenue in the quarter ending September 30, 2023 was $9.28M, a -51.19% decrease year-over-year. In the year 2022, Aclaris Therapeutics had annual revenue of $29.75M with 340.05% growth.

Revenue (ttm)
$21.43M
Revenue Growth
-8.80%
P/S Ratio
3.47
Revenue / Employee
$214,320
Employees
100
Market Cap
74.38M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202229.75M22.99M
340.05%
Dec 31, 20216.76M279.00K
4.30%
Dec 31, 20206.48M2.26M
53.35%
Dec 31, 20194.23M-1.92M
-31.28%
Dec 31, 20186.15M4.47M
265.48%
Dec 31, 20171.68M--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Champions Oncology 49.98M
Bionano Genomics 33.61M
CollPlant Biotechnologies 10.72M
Curis 10.21M
Clearside Biomedical 2.21M
Revenue Rankings

ACRS News

More News